Biemans VBC, van der Woude CJ, Dijkstra G, van der Meulen-de Jong AE, et al. Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment. Aliment Pharmacol Ther 2020;52:123-134.
PMID: 32441396